|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.530 CNY | -0.79% |
|
-5.52% | -22.37% |
| Market Cap | 3.38B 500M 432M 397M 373M 702M 47.21B 708M 4.7B 1.83B 23.17B 1.88B 1.84B 80.16B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.63B 390M 336M 309M 291M 547M 36.79B 551M 3.66B 1.43B 18.06B 1.46B 1.43B 62.47B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
23.75% | Yield 2024 |
0.62% | Yield 2025 | - |
| 1 day | -0.79% | ||
| 1 week | -5.52% | ||
| Current month | -11.62% | ||
| 1 month | -18.06% | ||
| 3 months | -22.77% | ||
| 6 months | -22.61% | ||
| Current year | -22.37% |
| 1 week | 7.45 |  | 8.06 |
| 1 month | 7.45 | | 9.29 |
| Current year | 7.45 | | 10.89 |
| 1 year | 7.45 | | 13.28 |
| 3 years | 6.3 | | 14.55 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 2023-04-05 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 2025-04-29 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 2023-05-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 2020-08-17 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 2012-07-31 |
Si Yu Shen
BRD | Director/Board Member | 44 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -5.52% | -26.75% | -41.63% | 504M | |
| +1.09% | +1.90% | +10.31% | +83.51% | 45.7B | |
| +1.75% | +5.43% | +51.14% | +95.77% | 34B | |
| -1.63% | -1.90% | -10.16% | +34.27% | 11.73B | |
| -1.60% | -3.36% | +10.83% | +92.61% | 11.48B | |
| +1.54% | +3.33% | +39.31% | +130.57% | 9.28B | |
| -0.92% | -0.17% | +16.72% | +40.48% | 7.21B | |
| +0.44% | +1.05% | +43.19% | -17.83% | 6.62B | |
| -0.93% | -0.36% | +29.24% | +232.57% | 6.44B | |
| -0.63% | -3.58% | -37.81% | -7.82% | 5.01B | |
| Average | -0.14% | -0.41% | +12.60% | +64.25% | 13.8B | |
| Weighted average by Cap. | +0.58% | +0.49% | +21.54% | +82.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 75.71M 65.31M 60.05M 56.52M 106M 7.14B 107M 712M 277M 3.51B 284M 278M 12.13B | 447M 66.08M 57.01M 52.41M 49.33M 92.7M 6.24B 93.48M 621M 242M 3.06B 248M 243M 10.59B |
| Net income | 128M 18.9M 16.3M 14.99M 14.11M 26.51M 1.78B 26.73M 178M 69.15M 875M 70.92M 69.41M 3.03B | 47.48M 7.03M 6.06M 5.57M 5.25M 9.86M 663M 9.94M 66.04M 25.71M 325M 26.37M 25.81M 1.13B |
| Net Debt | -734M -109M -93.64M -86.09M -81.03M -152M -10.24B -154M -1.02B -397M -5.03B -407M -399M -17.39B | -746M -110M -95.29M -87.6M -82.46M -155M -10.42B -156M -1.04B -404M -5.12B -415M -406M -17.7B |
Employees
312
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-17 | 7.530 ¥ | -0.79% | 3,334,395 |
| 26-06-16 | 7.590 ¥ | -3.68% | 4,293,028 |
| 26-06-15 | 7.880 ¥ | -0.88% | 1,964,289 |
| 26-06-12 | 7.950 ¥ | +1.66% | 1,556,993 |
| 26-06-11 | 7.820 ¥ | -1.88% | 1,443,332 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
